CA2303820A1 - Metal compounds, mixed or sulphated, as phosphate binders - Google Patents
Metal compounds, mixed or sulphated, as phosphate binders Download PDFInfo
- Publication number
- CA2303820A1 CA2303820A1 CA002303820A CA2303820A CA2303820A1 CA 2303820 A1 CA2303820 A1 CA 2303820A1 CA 002303820 A CA002303820 A CA 002303820A CA 2303820 A CA2303820 A CA 2303820A CA 2303820 A1 CA2303820 A1 CA 2303820A1
- Authority
- CA
- Canada
- Prior art keywords
- sulphate
- metal compound
- calcium
- mixed metal
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/244—Lanthanides; Compounds thereof
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01F—COMPOUNDS OF THE METALS BERYLLIUM, MAGNESIUM, ALUMINIUM, CALCIUM, STRONTIUM, BARIUM, RADIUM, THORIUM, OR OF THE RARE-EARTH METALS
- C01F11/00—Compounds of calcium, strontium, or barium
- C01F11/18—Carbonates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01F—COMPOUNDS OF THE METALS BERYLLIUM, MAGNESIUM, ALUMINIUM, CALCIUM, STRONTIUM, BARIUM, RADIUM, THORIUM, OR OF THE RARE-EARTH METALS
- C01F5/00—Compounds of magnesium
- C01F5/24—Magnesium carbonates
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01G—COMPOUNDS CONTAINING METALS NOT COVERED BY SUBCLASSES C01D OR C01F
- C01G49/00—Compounds of iron
- C01G49/009—Compounds containing, besides iron, two or more other elements, with the exception of oxygen or hydrogen
Abstract
A mixed metal compound for pharmaceutical use is free from aluminium and has a phosphate binding capacity of at least 30 %, by weight of the total weight of phosphate present, over a pH range of from 2-8. The compound is especially useful for treatment of hyperphosphataemia. The metals are preferably iron (III) and at least one of calcium, magnesium, lanthanum and cerium. A metal sulphate for pharmaceutical use is selected from at least one of calcium, lanthanum and cerium sulphate compounds and has a phosphate binding capacity of at least 30 % by weight of the total phosphate present, over a pH range from 2-8.
Claims (14)
1. A solid mixed metal compound for use as a medicament, which mixed metal compound is obtainable by formation of a precipitate thereof from a solution of a mixture of metallic salts, which mixed metal compound is free from aluminium and contains the metals iron (III) and at least one of magnesium, calcium, lanthanum and cerium and has a phosphate binding capacity of at least 30% by weight of the total weight of the phosphate present, over a pH range of 2-8.
2. A solid mixed metal compound according to claim 1, having a phosphate binding capacity of at least 30%, by weight of the total weight of phosphate present, over a pH range of from 3-7.
3. A solid mixed metal compound according to any preceding claim, which contains at least one of hydroxyl and carbonate ions.
4. A solid mixed metal compound according to claim 3, which additionally contains at least one of sulphate, chloride and oxide.
5. A solid mixed metal compound for use as a medicament, which mixed metal compound is a hydroxy carbonate containing each of iron (III) and magnesium, free from aluminium and having a phosphate binding capacity of at least 30% by weight of the total weight of the phosphate present, over a pH range of 2-8.
6. Use, in a method of preparing a medicament for treatment of hyperphosphataemia, of a mixed metal compound according to any preceding claim.
7. Use, in a method of preparing a medicament for treatment of hyperphosphataemia, of a metal sulphate material selected from at least one of calcium, lanthanum and cerium sulphate compounds treated with an alkali solution.
8. Use according to claim 7, wherein the alkali is sodium hydroxide.
9. Use according to claim 8, wherein the metal sulphate is treated with an aqueous sodium hydroxide solution.
10. Use according to any one of claims 7 to 9, wherein the metal sulphate compound is calcium sulphate.
11. A metal sulphate material, for use as a medicament, selected from at least one of calcium, lanthanum and cerium sulphate compounds treated with an aqueous solution of an alkaline hydroxide, which said material comprises a solid material.
12. A metal sulphate material according to claim 11, which metal sulphate material has a phosphate binding capacity of at least 30%, by weight of the total weight of phosphate present, over a pH range of from 2-8.
13. A method of preparing a metal sulphate material, which method comprises treating a metal sulphate comprising a solid material selected from at least one of calcium, lanthanum and cerium sulphate with an alkali solution.
14. A method according to claim 13, wherein the metal sulphate is calcium sulphate.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9720061.2A GB9720061D0 (en) | 1997-09-19 | 1997-09-19 | Metal compounds as phosphate binders |
GB9720061.2 | 1997-09-19 | ||
PCT/GB1998/002834 WO1999015189A1 (en) | 1997-09-19 | 1998-09-18 | Metal compounds, mixed or sulphated, as phosphate binders |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2303820A1 true CA2303820A1 (en) | 1999-04-01 |
CA2303820C CA2303820C (en) | 2010-06-15 |
Family
ID=10819414
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA2303820A Expired - Lifetime CA2303820C (en) | 1997-09-19 | 1998-09-18 | Metal compounds, mixed or sulphated, as phosphate binders |
Country Status (20)
Country | Link |
---|---|
US (4) | US6926912B1 (en) |
EP (2) | EP1015002B1 (en) |
JP (3) | JP4149659B2 (en) |
KR (2) | KR100823565B1 (en) |
CN (2) | CN1268347C (en) |
AT (2) | ATE332699T1 (en) |
AU (1) | AU9173398A (en) |
BR (1) | BR9812223A (en) |
CA (1) | CA2303820C (en) |
CY (2) | CY1106174T1 (en) |
DE (2) | DE69835217T2 (en) |
DK (2) | DK1015002T3 (en) |
ES (2) | ES2268788T3 (en) |
GB (1) | GB9720061D0 (en) |
HK (1) | HK1098390A1 (en) |
HU (2) | HU230611B1 (en) |
NZ (1) | NZ503136A (en) |
PL (1) | PL194211B1 (en) |
PT (2) | PT1015002E (en) |
WO (1) | WO1999015189A1 (en) |
Families Citing this family (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9720061D0 (en) * | 1997-09-19 | 1997-11-19 | Crosfield Joseph & Sons | Metal compounds as phosphate binders |
DE19917705C1 (en) * | 1999-04-20 | 2000-12-28 | Vitasyn Gmbh | Agents for the therapy of hyperphosphataemia |
US20060083791A1 (en) | 2002-05-24 | 2006-04-20 | Moerck Rudi E | Rare earth metal compounds methods of making, and methods of using the same |
US20040161474A1 (en) * | 2002-05-24 | 2004-08-19 | Moerck Rudi E. | Rare earth metal compounds methods of making, and methods of using the same |
CN100526219C (en) * | 2002-08-14 | 2009-08-12 | 爱尔达纳米公司 | Rare earth metal compounds, methods of making, and methods of using the same |
EP1647524A3 (en) * | 2002-08-14 | 2006-09-13 | Altair Nanomaterials Inc. | Rare earth metal compounds, methods of making, and methods of using the same |
DE202004021169U1 (en) * | 2003-08-26 | 2007-03-01 | Shire Holdings Ag | Pharmaceutical formulation containing lanthanum compounds |
DE102004031181A1 (en) * | 2004-06-28 | 2006-01-19 | Vifor (International) Ag | phosphate adsorbent |
KR20070054191A (en) * | 2004-07-27 | 2007-05-28 | 샤이어 파마세우티컬, 인크. | Method of treating hyperphosphataemia using lanthanum hydroxycarbonate |
JP2008526771A (en) * | 2004-12-30 | 2008-07-24 | ジェンザイム コーポレーション | Zinc-containing treatment for hyperphosphatemia |
GB0502787D0 (en) * | 2005-02-10 | 2005-03-16 | Ineos Silicas Ltd | Pharmaceuticlly active compounds, their manufacture, compositions containing them and their use |
TW200731981A (en) * | 2005-06-09 | 2007-09-01 | Pharma Co Ltd J | Oral agent for absorbing phosphorus ion in foods or drugs and producing process thereof |
EP1951266A2 (en) | 2005-09-02 | 2008-08-06 | Genzyme Corporation | Method for removing phosphate and polymer used therefore |
AR060690A1 (en) * | 2005-11-08 | 2008-07-10 | Genzyme Corp | POLYMERS CONTAINING MAGNESIUM FOR HYPERPHOSPHATEMIA |
MY157620A (en) * | 2006-01-31 | 2016-06-30 | Cytochroma Dev Inc | A granular material of a solid water-soluble mixed metal compound capable of binding phosphate |
GB0601899D0 (en) * | 2006-01-31 | 2006-03-08 | Ineos Silicas Ltd | Compositions |
AU2016213745B2 (en) * | 2006-01-31 | 2019-03-14 | Cytochroma Development Inc. | Granular Material Comprising Water-Insoluble Inorganic Phosphate Binders |
BRPI0621776A2 (en) * | 2006-06-29 | 2011-12-20 | Pharma Co Ltd J | therapeutic medicinal preventive agent for decreasing phosphorus, oral agent for adsorbing phosphate ions contained in food, beverages, and process for producing it |
US20100135950A1 (en) * | 2006-07-05 | 2010-06-03 | Genzyme Corporation | Iron(II)-Containing Treatments for Hyperphosphatemia |
PT2319804E (en) | 2006-12-14 | 2014-11-24 | Novartis Ag | Iron(iii)-carbohydrate based phosphate adsorbent |
EP1932807A1 (en) * | 2006-12-14 | 2008-06-18 | Novartis AG | Inorganic compounds |
JP4513819B2 (en) | 2007-03-19 | 2010-07-28 | 株式会社日立製作所 | Video conversion device, video display device, and video conversion method |
GB0714670D0 (en) * | 2007-07-27 | 2007-09-05 | Ineos Healthcare Ltd | Use |
GB0720220D0 (en) | 2007-10-16 | 2007-11-28 | Ineos Healthcare Ltd | Compound |
NZ594730A (en) * | 2009-03-02 | 2013-06-28 | Vifor Int Ag | Phosphate adsorbent comprising calcium, magnesium and iron salts for the treatment of chronic kidney deficiency and/or haemodialysis patients |
JP2012523413A (en) * | 2009-04-10 | 2012-10-04 | サイプレス ファーマシューティカルズ, インコーポレイテッド | Phosphate-binding magnesium salt and use thereof |
US8247000B2 (en) | 2009-04-10 | 2012-08-21 | Cypress Pharmaceutical, Inc. | Phosphate-binding magnesium salts and uses thereof |
JP5336932B2 (en) * | 2009-05-29 | 2013-11-06 | 株式会社東芝 | Water purification material, water purification method, phosphate fertilizer precursor and method for producing phosphate fertilizer precursor |
GB0913525D0 (en) * | 2009-08-03 | 2009-09-16 | Ineos Healthcare Ltd | Method |
DE102009045899B4 (en) * | 2009-10-21 | 2012-03-22 | Freie Universität Berlin | Bismuth-containing composition for reducing the phosphate concentration in liquids |
GB201001779D0 (en) | 2010-02-04 | 2010-03-24 | Ineos Healthcare Ltd | Composition |
US8961917B2 (en) | 2010-05-12 | 2015-02-24 | Spectrum Pharmaceuticals, Inc. | Lanthanum carbonate hydroxide, lanthanum oxycarbonate and methods of their manufacture and use |
DE102011112898A1 (en) | 2011-09-08 | 2013-03-14 | Charité - Universitätsmedizin Berlin | Nanoparticulate phosphate adsorbent based on maghemite or maghemite / magnetite, its preparation and uses |
US9394318B2 (en) | 2012-11-30 | 2016-07-19 | Cypress Pharmaceuticals, Inc. | Crystal polymorph of magnesium glycinate dihydrate and process for its preparation |
EP3873490A1 (en) | 2018-10-25 | 2021-09-08 | EirGen Pharma Ltd. | Methods of treatment with mixed metal compounds |
CN112816575A (en) * | 2020-12-29 | 2021-05-18 | 平光制药股份有限公司 | Analysis method for phosphate binding force of sevelamer carbonate |
CN115024495B (en) * | 2022-06-27 | 2024-03-22 | 北京金康普食品科技有限公司 | Nutritional composition for improving calcium and phosphorus metabolism of nephrosis patient and application thereof |
Family Cites Families (140)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2222924A (en) * | 1936-12-10 | 1940-11-26 | Degussa | Preparation of cerium sulphate |
US2812344A (en) * | 1956-02-13 | 1957-11-05 | Ortho Pharma Corp | Ferrous calcium citrate complex |
FR1214473A (en) * | 1959-01-07 | 1960-04-08 | Process for preparing a catalyst based on cerium hydroxide | |
BE590192A (en) | 1959-04-27 | |||
US3395211A (en) * | 1965-12-10 | 1968-07-30 | Carter Wallace | Tableting process |
US3539306A (en) * | 1966-07-25 | 1970-11-10 | Kyowa Chem Ind Co Ltd | Process for the preparation of hydrotalcite |
US3879523A (en) | 1969-12-12 | 1975-04-22 | Kyowa Chem Ind Co Ltd | Composite metal hydroxides |
SU414849A1 (en) * | 1971-05-21 | 1977-09-05 | Харьковский домостроительный комбинат | Concrete mix |
BE792032A (en) | 1971-12-23 | 1973-03-16 | Baxter Laboratories Inc | MASS TRANSFER DEVICE WITH A SEMI-PERMEABLE MEMBRAME ARRANGED IN A SPIRAL AND PRESENT A LOW VOLUME OF FLUID |
NL174720C (en) | 1973-12-13 | 1984-08-01 | Philips Nv | IMAGE DISPLAY CELL AND METHOD FOR THE MANUFACTURE OF A LIQUID CRYSTALLINE P-N-BUTYL-P'-ALKOXYAZOBENZENE. |
JPS5417518Y2 (en) | 1975-06-05 | 1979-07-05 | ||
PL110490B1 (en) | 1976-05-19 | 1980-07-31 | Politechnika Poznanska | Agent for preparing hydrophobic solutions extracting ions of non ferrous metals from aqueous solutions also a method of producing an agent for preparing hydrophobic solutions extracting ions of non ferrous metals |
DE2642984C3 (en) | 1976-09-24 | 1980-01-24 | Maschinenfabrik Karl Brieden & Co, 4630 Bochum | Discharge line with discharge at the front |
FR2435442A1 (en) | 1978-09-07 | 1980-04-04 | Om Lab Sa | SYNTHETIC MAGNESIUM AND ALUMINUM SILICATE, PROCESS FOR PRODUCING THE SAME, AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME |
US4192900A (en) | 1978-10-12 | 1980-03-11 | Merck & Co., Inc. | Texturized starch products |
DE2845326C2 (en) * | 1978-10-18 | 1985-05-23 | Beiersdorf Ag, 2000 Hamburg | Use of a specific microdisperse, amorphous, porous silica for the production of digoxin-containing tablets with a strongly accelerated release of active ingredient |
DE3039997A1 (en) | 1980-10-23 | 1982-06-03 | Bayer Ag, 5090 Leverkusen | PHOSPHONOHYDROXYACETONITRILE, A METHOD FOR THE PRODUCTION THEREOF AND ITS USE AS AN INTERMEDIATE PRODUCT FOR THE PRODUCTION OF MEDICINAL PRODUCTS |
US4351814A (en) * | 1980-12-18 | 1982-09-28 | Kyowa Chemical Industry Co., Ltd. | Hydrotalcites having a hexagonal needle-like crystal structure and process for production thereof |
JPS57156419A (en) * | 1981-03-24 | 1982-09-27 | Kyowa Chem Ind Co Ltd | Remedy for sideropenia |
US4514389A (en) | 1981-05-06 | 1985-04-30 | Kyowa Chemical Industry Co. Ltd. | Gastric antacid and method for controlling pH of gastric juice |
CA1198674A (en) | 1981-11-23 | 1985-12-31 | Rorer International (Holdings) Inc. | Antacid compositions |
US4458026A (en) * | 1982-06-02 | 1984-07-03 | Union Carbide Corporation | Catalysts for aldol condensations |
US4582705A (en) * | 1982-07-12 | 1986-04-15 | Leonard Primes | Composition for detoxification |
DE3228231A1 (en) * | 1982-07-28 | 1984-02-02 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V., 8000 München | MEDICINAL PRODUCTS, CALCIUM MIXED SALTS OF POLYMERS, ANIONIC CARBONIC ACIDS AND / OR SULFURIC ACID ESTERS, PROCESS FOR THEIR PRODUCTION AND THEIR USE |
JPS606619A (en) * | 1983-06-27 | 1985-01-14 | Kyowa Chem Ind Co Ltd | Remedy for hypoferremia and its preparation |
GB8317595D0 (en) | 1983-06-29 | 1983-08-03 | Reckitt & Colmann Prod Ltd | Pharmaceutical compositions |
US4609543A (en) * | 1983-11-14 | 1986-09-02 | Nabisco Brands, Inc. | Soft homogeneous antacid tablet |
JPS60131604A (en) * | 1983-12-20 | 1985-07-13 | Victor Co Of Japan Ltd | Magnetic recording and reproducing element |
DE3346943A1 (en) | 1983-12-24 | 1985-07-04 | Bayer Ag, 5090 Leverkusen | Preparation of hydrotalcite with improved properties |
DE3402878A1 (en) * | 1984-01-27 | 1985-08-01 | Algina AG, Zug | MEDICINAL PRODUCTS AND THE USE OF HEAVY-SOLUBLE CALCIUM AND / OR MAGNESIUM COMPOUNDS AS MEDICINAL PRODUCTS |
FR2559755A1 (en) * | 1984-02-20 | 1985-08-23 | Rhone Poulenc Spec Chim | CERIC OXIDE WITH NEW MORPHOLOGICAL CHARACTERISTICS AND METHOD OF OBTAINING THE SAME |
JPS6136222A (en) * | 1984-07-26 | 1986-02-20 | Chugai Pharmaceut Co Ltd | Remedy for hyperphosphatemia |
US4566986A (en) * | 1984-08-31 | 1986-01-28 | Waldmann John J | Flocculating agents and processes for making them |
DE3520108A1 (en) * | 1985-06-05 | 1986-12-11 | Varta Batterie Ag, 3000 Hannover | POSITIVE COLLECTOR ELECTRODE FOR ACCUMULATORS WITH ALKALINE ELECTROLYTE |
JPH06705B2 (en) * | 1985-12-19 | 1994-01-05 | 旭化成工業株式会社 | Phosphate ion fixing agent |
US6749864B2 (en) | 1986-02-13 | 2004-06-15 | Takeda Chemical Industries, Ltd. | Stabilized pharmaceutical composition |
US4871392A (en) | 1986-05-23 | 1989-10-03 | American Cyanamid Company | Aqueous suspension concentrate compositions of pendimethalin |
US4801454A (en) | 1986-07-17 | 1989-01-31 | The Proctor & Gamble Company | Processes for making colored pharmaceutical compositions |
EP0300853B1 (en) * | 1987-06-29 | 1991-09-18 | Rhone-Poulenc Chimie | Process for obtaining a cerium oxide |
US4786510A (en) * | 1987-07-02 | 1988-11-22 | The Procter & Gamble Company | Calcium-iron mineral supplements |
US4994283A (en) * | 1987-07-02 | 1991-02-19 | The Procter & Gamble Company | Iron-calcium mineral supplements with enhanced bioavailability |
DE3801382A1 (en) * | 1988-01-19 | 1989-08-03 | Ebner Anlagen & Apparate | Process and plant for converting sodium sulphate into sodium hydroxide |
DE68916983T2 (en) * | 1988-02-25 | 1995-01-19 | Yamanouchi Europ Bv | Process for the manufacture of pharmaceutical granules. |
HU201880B (en) | 1988-06-21 | 1991-01-28 | Semmelweis Orvostudomanyi Egye | Process for producing pharmaceutical compositions for profilacting and treating renal diseases and for diminishing frequency of extracorporalis dialysis |
GB8826333D0 (en) | 1988-11-10 | 1988-12-14 | Unilever Plc | Oral compositions |
GB8902581D0 (en) | 1989-02-06 | 1989-03-22 | Telephone Cables Ltd | Optical fibre cable core |
US5153156A (en) | 1989-04-18 | 1992-10-06 | Aristech Chemical Corporation | Process for making efficient anionic clay catalyst, catalysts made thereby, and method of making isophorone |
FR2647433B1 (en) * | 1989-05-23 | 1991-10-31 | Lafarge Coppee Da | PROCESS FOR THE AQUEOUS PREPARATION OF PURIFIED CALCIUM SULFATE |
US4970079A (en) * | 1989-06-05 | 1990-11-13 | Purdue Research Foundation | Method and composition of oxy-iron compounds for treatment of hyperphosphatemia |
US5112604A (en) | 1989-09-01 | 1992-05-12 | Riker Laboratories, Inc. | Oral suspension formulation |
ES2018952A6 (en) | 1989-10-17 | 1991-05-16 | Walton Sa | Procedure for preparation of antacid compositions with a prolonged gastric residence time. |
JP2918619B2 (en) | 1990-04-06 | 1999-07-12 | 花王株式会社 | Method for producing metal magnetic powder and coating film for magnetic recording medium |
JPH0414849A (en) * | 1990-05-09 | 1992-01-20 | Shibayama Kikai Kk | Method of removing a semiconductor wafer in chuck mechanism |
ATE136869T1 (en) | 1990-06-08 | 1996-05-15 | Commw Scient Ind Res Org | SORPENT FOR ETHYLENE |
US5300302A (en) | 1990-10-04 | 1994-04-05 | Nestec S.A. | Pharmaceutical composition in gel form in a dispensing package |
DE4036757A1 (en) * | 1990-11-17 | 1992-05-21 | Bayer Ag | ANTAZIDA PREPARATION WITH EXTENDED STOMACH TEMPERING |
GB2253164B (en) * | 1991-02-22 | 1994-10-05 | Hoechst Uk Ltd | Improvements in or relating to electrostatic coating of substrates of medicinal products |
GB2254556B (en) * | 1991-04-11 | 1995-04-12 | Fisons Plc | Formulations containing linolenic acid |
US5246899A (en) | 1991-08-16 | 1993-09-21 | Amoco Corporation | Simplified preparation of hydrotalcite-type clays |
JPH05155776A (en) * | 1991-12-02 | 1993-06-22 | Otsuka Pharmaceut Factory Inc | Therapeutic agent for hyperphosphatemia |
JPH05208816A (en) * | 1992-01-28 | 1993-08-20 | Sumitomo Metal Mining Co Ltd | Production of cerium hydroxide and cerium oxide |
WO1993022237A1 (en) | 1992-04-30 | 1993-11-11 | J.M. Huber Corporation | Method for production of synthetic hydrotalcite |
US5380542A (en) | 1992-06-19 | 1995-01-10 | Rhone-Poulenc Specialties Chemical Co. | Dietary fiber compositions for use in foods |
US5273767A (en) | 1992-09-09 | 1993-12-28 | Merck & Co., Inc. | Rapidly hydrating gums |
WO1994009798A1 (en) | 1992-10-29 | 1994-05-11 | C-P Technology Limited Partnership | Mixtures or complexes containing calcium and sulfate |
NL9201907A (en) | 1992-11-02 | 1994-06-01 | Tno | Peristaltic mixing reactor and peristaltic valve pump. |
DE4239442C2 (en) * | 1992-11-24 | 2001-09-13 | Sebo Gmbh | Use of an adsorbent material modified with polynuclear metal oxide hydroxides for the selective elimination of inorganic phosphate from protein-containing liquids |
CA2110313C (en) * | 1992-12-01 | 2004-10-26 | Edward John Roche | Pharmaceutical compositions containing a guanidinothiazole compound and antacids |
US5506248A (en) | 1993-08-02 | 1996-04-09 | Bristol-Myers Squibb Company | Pharmaceutical compositions having good dissolution properties |
TW397686B (en) | 1993-08-11 | 2000-07-11 | Takeda Chemical Industries Ltd | Antacid compositions and pharmaceutical compositions |
WO1995011033A1 (en) | 1993-10-22 | 1995-04-27 | Commonwealth Scientific And Industrial Research Organisation | Polyoxometallates in the treatment of flavivirus infections |
TW390813B (en) | 1994-04-29 | 2000-05-21 | Merck & Co Inc | Wet granulation formulation for bisphosphonic acids |
US5976506A (en) | 1994-09-21 | 1999-11-02 | Chesebrough-Pond's Usa Co. | Oral compositions |
GB9506126D0 (en) * | 1995-03-25 | 1995-05-10 | Johnson Matthey Plc | Pharmaceutical composition and method |
US6124525A (en) | 1995-09-20 | 2000-09-26 | The University Of Queensland | ACC synthase genes from pineapple, papaya and mango |
US5571336A (en) * | 1995-09-29 | 1996-11-05 | Wurzburger; Stephen R. | Base solution for cleaning aluminum |
DE19547356A1 (en) * | 1995-12-19 | 1997-06-26 | Vifor Int Ag | Adsorbent for phosphate from aqueous medium, its preparation and use |
ES2133246T3 (en) | 1996-01-25 | 2004-09-16 | Colin Leslie Young | STOMACH ACTION MOLUSQUICIDE. |
SE9602442D0 (en) | 1996-06-20 | 1996-06-20 | Astra Ab | Administration of pharmaceuticals |
US6287596B1 (en) * | 1996-07-12 | 2001-09-11 | Daiichi Pharmaceutical Co., Ltd. | Quickly disintegratable compression-molded materials and process for producing the same |
US5654011A (en) * | 1996-07-30 | 1997-08-05 | Energetics, Inc. | Dietary supplements |
JPH1059842A (en) | 1996-08-13 | 1998-03-03 | Lion Corp | Composition for tablet and making tablet |
JPH10101569A (en) | 1996-10-01 | 1998-04-21 | Eisai Co Ltd | Antacid |
JPH10236960A (en) | 1997-02-24 | 1998-09-08 | Lion Corp | Composition containing antacid agent |
TW592727B (en) * | 1997-04-04 | 2004-06-21 | Chugai Pharmaceutical Co Ltd | Phosphate-binding polymer preparations |
JP3835638B2 (en) | 1997-06-13 | 2006-10-18 | カルソニックカンセイ株式会社 | Air conditioner for automobile |
GB9720061D0 (en) * | 1997-09-19 | 1997-11-19 | Crosfield Joseph & Sons | Metal compounds as phosphate binders |
US6028023A (en) * | 1997-10-20 | 2000-02-22 | Bulldog Technologies U.S.A., Inc. | Process for making, and use of, anionic clay materials |
KR20010041609A (en) * | 1998-03-06 | 2001-05-25 | 유란드 인터내셔날 에스.피.아. | Fast disintegrating tablets |
JPH11335269A (en) * | 1998-05-19 | 1999-12-07 | Hisamitsu Pharmaceut Co Inc | Solid pharmaceutical preparation for oral administration of gene-related medicine |
CA2336954A1 (en) * | 1998-07-10 | 2000-01-20 | Motorola, Inc. | Method and apparatus in a wireless communication system for using a selective call receiver to provide demographic information, redeem coupons, and emulate affinity cards |
US6171678B1 (en) * | 1998-07-14 | 2001-01-09 | Bayer Antwerp N.V. | Polyurethane carpet backings with improved tuft bind |
JP2000086537A (en) | 1998-09-11 | 2000-03-28 | Fuji Chem Ind Co Ltd | Inorganic compound saccharide composition, vehicle, rapidly disintegrating compression molded product, and their production |
SA99191255B1 (en) | 1998-11-30 | 2006-11-25 | جي دي سيرل اند كو | celecoxib compounds |
KR100331529B1 (en) * | 1999-06-16 | 2002-04-06 | 민경윤 | Composition for Oral Administration of Hardly Soluble Antifungal Agent and Process for the Preparation Thereof |
US6448323B1 (en) * | 1999-07-09 | 2002-09-10 | Bpsi Holdings, Inc. | Film coatings and film coating compositions based on polyvinyl alcohol |
US6177581B1 (en) * | 1999-10-12 | 2001-01-23 | The Dow Chemical Company | Mixed-metal chelates and process for the preparation thereof |
US6733780B1 (en) * | 1999-10-19 | 2004-05-11 | Genzyme Corporation | Direct compression polymer tablet core |
DE19958007A1 (en) | 1999-12-02 | 2001-06-07 | Roehm Gmbh | Injection molding process for (meth) acrylate copolymers with tertiary ammonium groups |
WO2001049301A1 (en) | 2000-01-06 | 2001-07-12 | Marantech Holding, Llc | Methods of using electron active compounds for managing cancer |
AUPQ533700A0 (en) | 2000-01-28 | 2000-02-17 | Commonwealth Scientific And Industrial Research Organisation | Soil treatment method |
FR2809407B1 (en) | 2000-05-26 | 2002-08-30 | Rhodia Chimie Sa | USE OF HYDROTALCITE AS A FILLER IN POLYMER COMPOSITIONS |
US20030185886A1 (en) * | 2000-05-26 | 2003-10-02 | Hanmi Pharm. Co., Ltd. | Process for the preparation of rapidly disintegrating tablet |
US6720005B1 (en) | 2000-07-07 | 2004-04-13 | The State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University | Coated, platform-generating tablet |
IN192168B (en) | 2000-11-24 | 2004-03-06 | Council Scient Ind Res | |
CA2342007C (en) * | 2001-03-26 | 2009-10-20 | University Technologies International, Inc. | Determination of oil and water compositions of oil/water emulsions using low field nmr relaxometry |
US6576665B2 (en) * | 2001-04-03 | 2003-06-10 | Braintree Laboratories, Inc. | Encapsulated calcium acetate caplet and a method for inhibiting gastrointestinal phosphorous absorption |
US20040247696A1 (en) | 2001-07-05 | 2004-12-09 | Antelman Marvin S. | Methods of using electron active compounds for managing conditions afflicting mammals |
UA80682C2 (en) | 2001-08-06 | 2007-10-25 | Pharmacia Corp | Orally deliverable stabilized oral suspension formulation and process for the incresaing physical stability of thixotropic pharmaceutical composition |
DK1421944T3 (en) * | 2001-08-27 | 2008-03-31 | Kyowa Chem Ind Co Ltd | Antacid and laxative tablet |
AR036354A1 (en) | 2001-08-31 | 2004-09-01 | Takeda Chemical Industries Ltd | SOLID PREPARATION |
CN1284532C (en) | 2001-09-28 | 2006-11-15 | 株式会社三和化学研究所 | Cored molded article undergoing quick disintegration |
GB0204771D0 (en) | 2002-02-28 | 2002-04-17 | Phoqus Ltd | Fast disintegrating tablets |
US7300670B2 (en) | 2002-04-03 | 2007-11-27 | Unilab Pharmatech, Ltd. | Oral suspension formulation |
EP1501484B2 (en) | 2002-04-29 | 2010-07-07 | EGIS Gyógyszergyár Nyrt | A process for the preparation of tablets from pharmaceutically active substances having unfavourable tabletting properties with a granulating liquid comprising microcrystalline cellulose |
US20040161474A1 (en) | 2002-05-24 | 2004-08-19 | Moerck Rudi E. | Rare earth metal compounds methods of making, and methods of using the same |
AU2003263753A1 (en) | 2002-06-25 | 2004-01-06 | Rhodia, Inc. | Molecular weight reduction of polysaccharides by electron beams |
DE60310950T2 (en) | 2002-08-09 | 2007-11-15 | Albemarle Netherlands B.V. | FISCHER TROPSCH METHOD USING AN ICE-CONTAINING LAYERED MATERIAL |
JP4348426B2 (en) | 2002-08-29 | 2009-10-21 | 独立行政法人産業技術総合研究所 | Highly selective dephosphorizing agent and method for producing the same |
WO2005012194A1 (en) | 2003-01-28 | 2005-02-10 | The University Of Wyoming Research Corporation D/B/A Western Research Institute | Charge-based water filtration systems |
AR045068A1 (en) | 2003-07-23 | 2005-10-12 | Univ Missouri | FORMULATION OF IMMEDIATE RELEASE OF PHARMACEUTICAL COMPOSITIONS |
DE202004021169U1 (en) | 2003-08-26 | 2007-03-01 | Shire Holdings Ag | Pharmaceutical formulation containing lanthanum compounds |
US7381428B2 (en) | 2003-08-26 | 2008-06-03 | Shire International Licensing B.V. | Stabilized lanthanum carbonate compositions |
WO2005027876A1 (en) | 2003-08-28 | 2005-03-31 | Ranbaxy Laboratories Limited | Pharmaceutical compositions of benzimidazole and processes for their preparation |
US20050260271A1 (en) * | 2004-05-20 | 2005-11-24 | Eastman Kodak Company | Composition comprising layered host material with intercalated functional-active organic compound |
US8906940B2 (en) | 2004-05-25 | 2014-12-09 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
US20060177415A1 (en) | 2004-11-01 | 2006-08-10 | Burke Steven K | Once a day formulation for phosphate binders |
GB0502787D0 (en) | 2005-02-10 | 2005-03-16 | Ineos Silicas Ltd | Pharmaceuticlly active compounds, their manufacture, compositions containing them and their use |
JP4823547B2 (en) | 2005-03-28 | 2011-11-24 | 株式会社ジーシー | Paste-like dental alginate impression material composition |
SG184754A1 (en) | 2005-12-28 | 2012-10-30 | Takeda Pharmaceutical | Controlled release solid preparation |
MY157620A (en) | 2006-01-31 | 2016-06-30 | Cytochroma Dev Inc | A granular material of a solid water-soluble mixed metal compound capable of binding phosphate |
CA2645205C (en) | 2006-05-19 | 2012-12-04 | Norbrook Laboratories Limited | Stable aqueous suspension having palatable taste |
DK2319804T3 (en) | 2006-12-14 | 2015-01-19 | Novartis Ag | Iron (III) -carbohydrat-based phosphatadsorbens |
PT2319804E (en) | 2006-12-14 | 2014-11-24 | Novartis Ag | Iron(iii)-carbohydrate based phosphate adsorbent |
EP1946750A1 (en) | 2007-01-18 | 2008-07-23 | The Jordanian Pharmaceutical Manufacturing Co. | Co-precipitate, method for preparing the same and uses thereof |
WO2008129034A1 (en) | 2007-04-20 | 2008-10-30 | Euro Support Catalyst Group Bv | Hydrotalcite-like layered double hydroxide (ldh) composition and process of making same |
GB0714670D0 (en) | 2007-07-27 | 2007-09-05 | Ineos Healthcare Ltd | Use |
GB0720220D0 (en) | 2007-10-16 | 2007-11-28 | Ineos Healthcare Ltd | Compound |
GB0913525D0 (en) | 2009-08-03 | 2009-09-16 | Ineos Healthcare Ltd | Method |
GB201001779D0 (en) | 2010-02-04 | 2010-03-24 | Ineos Healthcare Ltd | Composition |
-
1997
- 1997-09-19 GB GBGB9720061.2A patent/GB9720061D0/en not_active Ceased
-
1998
- 1998-09-18 AT AT98944055T patent/ATE332699T1/en active
- 1998-09-18 CA CA2303820A patent/CA2303820C/en not_active Expired - Lifetime
- 1998-09-18 CN CNB988092336A patent/CN1268347C/en not_active Expired - Lifetime
- 1998-09-18 PT PT98944055T patent/PT1015002E/en unknown
- 1998-09-18 EP EP98944055A patent/EP1015002B1/en not_active Expired - Lifetime
- 1998-09-18 ES ES98944055T patent/ES2268788T3/en not_active Expired - Lifetime
- 1998-09-18 PT PT06013811T patent/PT1759704E/en unknown
- 1998-09-18 EP EP06013811A patent/EP1759704B1/en not_active Expired - Lifetime
- 1998-09-18 HU HU0900652A patent/HU230611B1/en active IP Right Revival
- 1998-09-18 NZ NZ503136A patent/NZ503136A/en not_active IP Right Cessation
- 1998-09-18 DK DK98944055T patent/DK1015002T3/en active
- 1998-09-18 KR KR1020007002892A patent/KR100823565B1/en not_active IP Right Cessation
- 1998-09-18 ES ES06013811T patent/ES2355925T3/en not_active Expired - Lifetime
- 1998-09-18 DE DE69835217T patent/DE69835217T2/en not_active Expired - Lifetime
- 1998-09-18 WO PCT/GB1998/002834 patent/WO1999015189A1/en not_active Application Discontinuation
- 1998-09-18 PL PL98339079A patent/PL194211B1/en not_active IP Right Cessation
- 1998-09-18 US US09/508,923 patent/US6926912B1/en not_active Expired - Lifetime
- 1998-09-18 AU AU91733/98A patent/AU9173398A/en not_active Abandoned
- 1998-09-18 HU HU0004527A patent/HU227666B1/en unknown
- 1998-09-18 BR BR9812223-1A patent/BR9812223A/en not_active Application Discontinuation
- 1998-09-18 DE DE69842028T patent/DE69842028D1/en not_active Expired - Lifetime
- 1998-09-18 KR KR1020077001491A patent/KR100997504B1/en not_active IP Right Cessation
- 1998-09-18 AT AT06013811T patent/ATE489958T1/en active
- 1998-09-18 CN CN2006100928025A patent/CN1911245B/en not_active Expired - Lifetime
- 1998-09-18 DK DK06013811.2T patent/DK1759704T3/en active
- 1998-09-18 JP JP2000512558A patent/JP4149659B2/en not_active Expired - Lifetime
-
2003
- 2003-07-10 US US10/615,797 patent/US7799351B2/en not_active Expired - Fee Related
-
2006
- 2006-09-28 CY CY20061101402T patent/CY1106174T1/en unknown
-
2007
- 2007-03-23 JP JP2007076097A patent/JP4929426B2/en not_active Expired - Lifetime
- 2007-06-05 HK HK07105937.8A patent/HK1098390A1/en not_active IP Right Cessation
- 2007-11-15 JP JP2007296734A patent/JP2008069173A/en active Pending
-
2010
- 2010-07-01 US US12/828,462 patent/US8568792B2/en not_active Expired - Fee Related
-
2011
- 2011-02-14 CY CY20111100186T patent/CY1111199T1/en unknown
-
2013
- 2013-10-28 US US14/065,162 patent/US9242869B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2303820A1 (en) | Metal compounds, mixed or sulphated, as phosphate binders | |
AU2077601A (en) | Catalyst systems for polycondensation reactions | |
RU95116374A (en) | COMPOSITIONS CONTAINING Dietary Supplements | |
EP1055642A3 (en) | Metal oxide doped cerium oxides, method for the preparation thereof, resin composition and cosmetic composition therewith | |
CN1964930A (en) | Hydraulic binder | |
CA2229020A1 (en) | High solids lime as a caustic replacement | |
CA1203364A (en) | Method for producing basic aluminium sulphate (iii) | |
CA2242331A1 (en) | Flocculant compositions and water treatment method using the same | |
CA2167890A1 (en) | Process for the preparation of aluminum salt solutions | |
GB2272375A (en) | Pharmaceutical composition | |
CA2313100A1 (en) | Absorbents | |
CA2112989A1 (en) | Compositions for Treating Waste Water Which Contains Heavy Metals | |
AUPN538295A0 (en) | Magnesiosilicate cation exchange compounds | |
JPS6245394A (en) | Simultaneous removal of arsenic and silicon | |
HUT73589A (en) | Compositions based on aluminium polychloride and on iron salts and method of preparation thereof and application thereof in water treatment | |
AU6679294A (en) | Method of preparing caesium salts from caesium aluminium alum | |
US3360345A (en) | Dry heating process for preparation of antacid compounds | |
CA1111767A (en) | Antacid composition | |
CN106823233B (en) | A method of distribution crystallisation preparation high stability consolidates arsenic mineral | |
JPS649928A (en) | Bathing composition | |
GB1406562A (en) | Steam cracking of hydrocarbons and catalyst for it | |
WO1999024365A1 (en) | Composition and process for the removal of the phosphate ion content of waters | |
Qu et al. | Synthesis of low hydrous zinc borate and its surface modifications | |
Alferova | Soda--Alkali Purification of Zinc Plant Waste Water | |
CA2597179A1 (en) | Process for the production of cesium compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKEX | Expiry |
Effective date: 20180918 |